In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Top Biopharma Pharma Stories of 2004

Executive Summary

Windhover's pick of the top pharma/ biotech stories of 2004 range from the firestorm over Vioxx and Celebrex, the problem of the blockbuster pharma model, the biogenerics that weren't, the pricing squeeze on drugs; greater scrutiny of clinical data from a beleaguered, gun-shy FDA; new uses of existing molecules, which "jump-started" companies looking for financing; the tail-end of Big Pharma consolidation; and the rise of oncology.


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts